ОПЫТ ПРИМЕНЕНИЯ КОМБИНИРОВАННОЙ АНТИГИПЕРТЕНЗИВНОЙ ТЕРАПИИ У БОЛЬНЫХ АБДОМИНАЛЬНЫМ ОЖИРЕНИЕМ

1. Hansson L. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension; principal results of the Hypertension Optimal Treatment (HOT) randomised trial// Lancet 1998; 351: 1755-1762.

2. Bakris G.L. Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker// J Clin Hypertens 2008; 10 (1 suppl 1): 27-32.

3. Sharma S.K., Ruggenenti P., Remuzzi G. Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination// Vascular Health and Risk Management 2007; 3(4): 453- 465.

4. Stanton T., Reid J.L. Fixed dose combination therapy in the treatment of hypertension// J Hum Hypertens 2002; 16: 75-78.

5. Jamerson K., Weber M.A., Bakris G.L., Dahlцf B., Pitt B., Shi V., Hester A., Gupte J., Gatlin M., Velazquez E.J. for the ACCOMPLISH trial investigators. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients// N Engl J Med 2008; 359: 2417-2428.

6. Dahlцf B., Sever P.S., Poulter N.R., et al for the ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre, randomised controlled tria// Lancet 2005; DOI: 10.1016/50140-6736- (05)67185-1.

7. Nelson C.R., Knapp D.A. Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians// Hypertension 2000; 36: 600-603.

8. Knight E.L., Glynn R.J., Levin R., et al. Failure of evidence-based medicine in the treatment of hypertension in older patients// J Gen Intern Med 2000; 15: 702-709.

9. Saseen J.J., MacLaughlin E.J., Westfall J.M. Treatment of uncomplicated hypertension: are ACE inhibitors and calcium channel blockers as effective as diuretics and beta-blockers?// J Am Board Fam Pract 2003; 16 (2): 156-164.

10. Stanton T., Reid J.L. Fixed dose combination therapy in the treatment of hypertension// J. Human Hypertension 2002; 16: 75-78.

11. Gojanovic B., Feihl F., Liaudet L. et al.Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension// JRAAS 2008; 9: 1–9.

12. Agrawal R., Marx A., Haller H.. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension// Hypertens 2006; 24: 185-92.

13. Poldermans D., Glazes R., Kargiannis S. et al. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension// Clin Ther 2007; 29: 279-289.

14. Jandeleit-Dahm K.A., Tikellis C., Reid C.M. et al. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes// J Hypertens 2005; 23: 463-473.

15. Elliott W.J., Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis// Lancet 2007; 369: 201-207.

16. Bakris G., Molitch M., Hewkin A. et al. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome// Diabetes Care 2006; 29: 2592-2597.